MEK inhibitors block growth of lung tumours with mutations in ataxia–telangiectasia mutated

ATM is a tumor suppressor often mutated in lung adenocarcinoma. In this study, the authors starting from a synthetic lethal screen, demonstrate that tumor cells with mutations in ATM exhibit increased sensitivity to MEK1/2 inhibition through the modulation of the AKT/mTOR pathway.

Guardado en:
Detalles Bibliográficos
Autores principales: Michal Smida, Ferran Fece de la Cruz, Claudia Kerzendorfer, Iris Z. Uras, Barbara Mair, Abdelghani Mazouzi, Tereza Suchankova, Tomasz Konopka, Amanda M. Katz, Keren Paz, Katalin Nagy-Bojarszky, Markus K. Muellner, Zsuzsanna Bago-Horvath, Eric B. Haura, Joanna I. Loizou, Sebastian M. B. Nijman
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2016
Materias:
Q
Acceso en línea:https://doaj.org/article/d580c8bada764855b9d9cdb7d5d53e6b
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:d580c8bada764855b9d9cdb7d5d53e6b
record_format dspace
spelling oai:doaj.org-article:d580c8bada764855b9d9cdb7d5d53e6b2021-12-02T14:39:50ZMEK inhibitors block growth of lung tumours with mutations in ataxia–telangiectasia mutated10.1038/ncomms137012041-1723https://doaj.org/article/d580c8bada764855b9d9cdb7d5d53e6b2016-12-01T00:00:00Zhttps://doi.org/10.1038/ncomms13701https://doaj.org/toc/2041-1723ATM is a tumor suppressor often mutated in lung adenocarcinoma. In this study, the authors starting from a synthetic lethal screen, demonstrate that tumor cells with mutations in ATM exhibit increased sensitivity to MEK1/2 inhibition through the modulation of the AKT/mTOR pathway.Michal SmidaFerran Fece de la CruzClaudia KerzendorferIris Z. UrasBarbara MairAbdelghani MazouziTereza SuchankovaTomasz KonopkaAmanda M. KatzKeren PazKatalin Nagy-BojarszkyMarkus K. MuellnerZsuzsanna Bago-HorvathEric B. HauraJoanna I. LoizouSebastian M. B. NijmanNature PortfolioarticleScienceQENNature Communications, Vol 7, Iss 1, Pp 1-13 (2016)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Michal Smida
Ferran Fece de la Cruz
Claudia Kerzendorfer
Iris Z. Uras
Barbara Mair
Abdelghani Mazouzi
Tereza Suchankova
Tomasz Konopka
Amanda M. Katz
Keren Paz
Katalin Nagy-Bojarszky
Markus K. Muellner
Zsuzsanna Bago-Horvath
Eric B. Haura
Joanna I. Loizou
Sebastian M. B. Nijman
MEK inhibitors block growth of lung tumours with mutations in ataxia–telangiectasia mutated
description ATM is a tumor suppressor often mutated in lung adenocarcinoma. In this study, the authors starting from a synthetic lethal screen, demonstrate that tumor cells with mutations in ATM exhibit increased sensitivity to MEK1/2 inhibition through the modulation of the AKT/mTOR pathway.
format article
author Michal Smida
Ferran Fece de la Cruz
Claudia Kerzendorfer
Iris Z. Uras
Barbara Mair
Abdelghani Mazouzi
Tereza Suchankova
Tomasz Konopka
Amanda M. Katz
Keren Paz
Katalin Nagy-Bojarszky
Markus K. Muellner
Zsuzsanna Bago-Horvath
Eric B. Haura
Joanna I. Loizou
Sebastian M. B. Nijman
author_facet Michal Smida
Ferran Fece de la Cruz
Claudia Kerzendorfer
Iris Z. Uras
Barbara Mair
Abdelghani Mazouzi
Tereza Suchankova
Tomasz Konopka
Amanda M. Katz
Keren Paz
Katalin Nagy-Bojarszky
Markus K. Muellner
Zsuzsanna Bago-Horvath
Eric B. Haura
Joanna I. Loizou
Sebastian M. B. Nijman
author_sort Michal Smida
title MEK inhibitors block growth of lung tumours with mutations in ataxia–telangiectasia mutated
title_short MEK inhibitors block growth of lung tumours with mutations in ataxia–telangiectasia mutated
title_full MEK inhibitors block growth of lung tumours with mutations in ataxia–telangiectasia mutated
title_fullStr MEK inhibitors block growth of lung tumours with mutations in ataxia–telangiectasia mutated
title_full_unstemmed MEK inhibitors block growth of lung tumours with mutations in ataxia–telangiectasia mutated
title_sort mek inhibitors block growth of lung tumours with mutations in ataxia–telangiectasia mutated
publisher Nature Portfolio
publishDate 2016
url https://doaj.org/article/d580c8bada764855b9d9cdb7d5d53e6b
work_keys_str_mv AT michalsmida mekinhibitorsblockgrowthoflungtumourswithmutationsinataxiatelangiectasiamutated
AT ferranfecedelacruz mekinhibitorsblockgrowthoflungtumourswithmutationsinataxiatelangiectasiamutated
AT claudiakerzendorfer mekinhibitorsblockgrowthoflungtumourswithmutationsinataxiatelangiectasiamutated
AT iriszuras mekinhibitorsblockgrowthoflungtumourswithmutationsinataxiatelangiectasiamutated
AT barbaramair mekinhibitorsblockgrowthoflungtumourswithmutationsinataxiatelangiectasiamutated
AT abdelghanimazouzi mekinhibitorsblockgrowthoflungtumourswithmutationsinataxiatelangiectasiamutated
AT terezasuchankova mekinhibitorsblockgrowthoflungtumourswithmutationsinataxiatelangiectasiamutated
AT tomaszkonopka mekinhibitorsblockgrowthoflungtumourswithmutationsinataxiatelangiectasiamutated
AT amandamkatz mekinhibitorsblockgrowthoflungtumourswithmutationsinataxiatelangiectasiamutated
AT kerenpaz mekinhibitorsblockgrowthoflungtumourswithmutationsinataxiatelangiectasiamutated
AT katalinnagybojarszky mekinhibitorsblockgrowthoflungtumourswithmutationsinataxiatelangiectasiamutated
AT markuskmuellner mekinhibitorsblockgrowthoflungtumourswithmutationsinataxiatelangiectasiamutated
AT zsuzsannabagohorvath mekinhibitorsblockgrowthoflungtumourswithmutationsinataxiatelangiectasiamutated
AT ericbhaura mekinhibitorsblockgrowthoflungtumourswithmutationsinataxiatelangiectasiamutated
AT joannailoizou mekinhibitorsblockgrowthoflungtumourswithmutationsinataxiatelangiectasiamutated
AT sebastianmbnijman mekinhibitorsblockgrowthoflungtumourswithmutationsinataxiatelangiectasiamutated
_version_ 1718390504907866112